Bavla: CORONA Remedies Private Limited, one of the fastest growing pharmaceutical companies in India today informed it is coming up with a hormonal product manufacturing plant in Bhayla, Ahmedabad. The construction of the facility has been completed. Commercial production is expected to commence in FY 2026. The company informed that the new facility will focus on producing a range of essential female hormone products, including treatments for conditions such as dysmenorrhoea, polycystic ovary...Read More

Bharuch: 518 kg cocaine worth Rs. 5,000 crore was found from Ankleshwar in Bharuch district of Gujarat in a joint operation of Delhi Police and Gujarat Police today. In addition to confiscating a consignment of 518 kilograms of cocaine, authorities also arrested five individuals linked to the case. The stock of cocaine was found in a private company named Aavkar Pharma Solution Services which is part of Aavkar Drugs Pvt Ltd. On 1st October, 562 kg cocaine and hydroponic ganja consignment w...Read More

Ahmedabad: Akums Drugs and Pharmaceuticals Limited (“AKUMS” or “The Company”), shall open the Bid / Offer Period in relation to its initial public offer of the Equity Shares (“Offer”) on Tuesday, July 30, 2024. The Offer comprises a fresh issue of such number of Equity Shares (face value ₹ 2 each) by the Company aggregating up to ₹ 6,800 million (the “Fresh Issue”) and offer for sale of up to 17,330,435 Equity Shares (“Offered Shares”) by certain existing shareholders...Read More

Ahmedabad: Emcure Pharmaceuticals Limited (the “Company”) proposes to open its initial public offering of Equity Shares (“Offer”) on Tuesday, July 02, 2024. The Anchor Investor Bid/Offer Period is one Working Day prior to Bid/Offer Opening Date, that is, Wednesday, July 03, 2024. Bid/ Offer Closing Date will be on Friday, July 05, 2024. The Price Band of the Offer has been fixed from ₹ 960 per Equity Share to ₹ 1008 per Equity Share. Bids can be made for a minimum of 14 Equity Sha...Read More

Gandhinagar: Cadila Pharmaceuticals today announced the launch of the world's first aqueous formulation of cholecalciferol, for the treatment of Vitamin D deficiency. It has been developed through totally indigenous research. The company said its aqueous cholecalciferol injection offers a solution with rapid correction of Vitamin D deficiency in short span of time, and enhances the efficacy of treatment by ensuring painless process. Key Features of Cadila Pharmaceuticals has announced abou...Read More

Dahej: Cadila Pharmaceuticals in a press release informed that its Rs. 200 crore Active Pharmaceutical Ingredients (API) Plant at Dahej in the Bharuch district has been inaugurated. The facility is equipped with the latest Distributed Control System (DCS) automation technology, the company informed in a release. Speaking on the occasion, Mr. Biswajit Mitra, Chief Mentoring Officer at Cadila Pharmaceuticals and Convener Pharma Panel, CII Gujarat State, said, “The DCS technology used in this...Read More

Gandhinagar: Mumbai based Lilavati Hospital's promoter family today launched Lilavati Pharmacy in Ahmedabad. The Mehta family, promoter of Lilavati hospital announced to open 500 such pharama stores in five years across India. Customers will be able to consult a doctor at the pharmacy itself and seek an appropriate line of treatment.The Lilavati Pharmacy project is being driven by Prashant Mehta, the promoter and Managing Director. Mehta is also leading Lilavati Hospital’s foray into Gujarat w...Read More

Mumbai: Gujarat headquartered Nirma Group has entered into definitive agreement to acquire 75% of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about INR 7,500 Crore, subject to closing adjustments. Nirma will make a mandatory open offer as per SEBI Regulations. This acquisition is subject to customary regulatory approvals. With this acquisition, the Nirma Group forays into Active Pharmaceutical Ingredient (API) platform and expands its existin...Read More

Ahmedabad: Cadila Pharmaceuticals Ltd., Ahmedabad signed an MoU with the government of Gujarat on Monday to invest Rs. 1,000 crores in different existing projects. The company in a release stated - Cadila Pharmaceuticals Ltd. will overall invest Rs. 1000 crores in a span of three yearsuntil 2025 for setting up an Active Pharmaceuticals Ingredients (APIs) plant at Dahej, Bharuch & Ankleshwar and the Formation of Tablet & Capsules at Dholka Dist. Plant. As Proposed, these plants wi...Read More